New developments in the induction and antiviral effectors of type I interferon - Wikidata - wikimedia - TriplyDB

New developments in the induction and antiviral effectors of type I interferon

New developments in the induction and antiviral effectors of type I interferon

http://www.wikidata.org/entity/Q37292441

about

IFITM proteins restrict viral membrane hemifusion.IFITM proteins restrict antibody-dependent enhancement of dengue virus infection Evolutionary conflicts between viruses and restriction factors shape immunity Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity Opposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plague TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A protein Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha Human genome-wide RNAi screen identifies an essential role for inositol pyrophosphates in Type-I interferon response The interferon-inducible gene viperin restricts West Nile virus pathogenesis Interferons and their receptors in birds: a comparison of gene structure, phylogenetic analysis, and cross modulation Two-stepping through time: mammals and viruses Protein Interferon-Stimulated Gene 15 Conjugation Delays but Does Not Overcome Coronavirus Proliferation in a Model of Fulminant Hepatitis A moderate increase in ambient temperature modulates the Atlantic cod (Gadus morhua) spleen transcriptome response to intraperitoneal viral mimic injection Resistance to simian immunodeficiency virus low dose rectal challenge is associated with higher constitutive TRIM5α expression in PBMC Herpes Simplex Virus and Interferon Signaling Induce Novel Autophagic Clusters in Sensory Neurons Innate nuclear sensor IFI16 translocates into the cytoplasm during the early stage of in vitro human cytomegalovirus infection and is entrapped in the egressing virions during the late stage.The interferon-induced gene Ifi27l2a is active in lung macrophages and lymphocytes after influenza A infection but deletion of Ifi27l2a in mice does not increase susceptibility to infection.2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo How Ebola virus counters the interferon system.The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells.Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms.Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production.IFN-ε is constitutively expressed by cells of the reproductive tract and is inefficiently secreted by fibroblasts and cell lines.A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication RIG-I-dependent antiviral immunity is effective against an RNA virus encoding a potent suppressor of RNAi.Six host-range restricted poxviruses from three genera induce distinct gene expression profiles in an in vivo mouse model Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity.Melanoma differentiation-associated gene 5 is critical for protection against Theiler's virus-induced demyelinating disease.Permissiveness of human hepatoma cell lines for HCV infection.S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity IFN type I and type II independent enhancement of B cell TLR7 expression by natural killer cells.Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses.Ubiquitination in the antiviral immune response Induction of the type I interferon response in neurological forms of Gaucher disease UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS.Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS

P2860

Q21558779-4E5EB055-1D2A-4814-96C1-42CF0B1B04B3 Q24311739-5F9DEC8E-7E69-4498-A59B-5A447A7331C3 Q27022032-3A0D058A-35B1-44B5-A920-9CDAFAE77226 Q27335125-92A91ABA-8577-4DF9-A57C-0D03C5340A66 Q27343051-A14E54ED-3586-47B8-8D0B-7FCE845922F4 Q27468803-84F7DFF0-2B3B-41CB-807B-78AE2E0C65D0 Q27928046-8A72223B-6B29-42EC-BE27-048271A2D998 Q28265144-CDADD714-EFE1-4169-A4B9-82F1BEB29346 Q28540195-9AA7FCEA-0D48-4D33-8F3B-697114CEC70B Q28594932-4FF2133F-398C-42F0-85C5-A9BFE28877F7 Q28649915-DACCEF10-99E9-4D27-B88F-78DC3DF3DA34 Q28709092-A92FE3C6-0B13-4893-958C-3DDE7351130B Q30049307-42498473-10E3-45EF-BA9A-4FBB988A5AFD Q30559646-7E593483-D4B3-4A39-BF19-4E62F58C3CA1 Q30579576-FD1F0E3F-446B-4574-82A0-DE7E67C38468 Q30744548-123923A7-FA12-4C02-AB2C-E4D2992C53A3 Q33743805-AAA447D3-F38E-4F1C-ACF7-39E5249C082E Q34128745-9DAB4E3E-5CC2-42F4-B680-73E9A3DEFABF Q34270459-1EE41CBB-F747-470F-9E21-E109FB909EE2 Q34298213-3CC924B9-CACA-4F82-AAA4-1FBE1C4E43CD Q34388476-AF3498F2-1209-4E78-9291-09BD0256D2C5 Q34616709-C00B22B9-7CBC-480A-8B70-6CA138657B7E Q34627384-417EEE55-D5DB-4DEF-8F50-4F0FBD799C65 Q34819672-DEBD7C99-A95B-4609-93DD-959F9F39AA5A Q34949247-2C53B501-5CA7-4A71-B3BD-7AFDA6BA2C3A Q35487689-02CBB55B-F7DC-4824-B0B3-651CEF420867 Q35588762-D83923AE-480C-43E6-9341-43B50F16467B Q35685675-CFE8992E-5E77-46E9-8679-8BA5B9CEE657 Q35685720-70FB5672-3B8E-42D7-A41A-D8D2F25D49A4 Q35689719-2987AAD0-7503-4295-9808-CE15FAEC5215 Q35866290-E05D053B-087D-4369-8584-A4C68CE3345C Q36003903-CBB29EB8-6870-4718-AA8D-BAC0318D3135 Q36016455-5B43FBFD-C6D0-4CB8-912E-FCF9B45EF1DE Q36232213-B6119002-FCED-407C-8F59-BA88D016CE82 Q36422111-6BFA50F2-969F-4CB4-8D8A-FB0556465E9B Q36567669-095678B2-E4B2-4B34-8DF7-7282EABDA8CE Q36640618-58D1C760-B7A7-4866-8601-8BECFC0A0F06 Q36898538-AA254954-EEB3-4DBF-9A23-C361BB68C7E4 Q36998981-9DB17F2B-E37F-45ED-BE19-5BBCEB8D11F7 Q37174376-85E3443C-6DAE-4005-8938-487C8AB2D025

P2860

New developments in the induction and antiviral effectors of type I interferon

http://www.wikidata.org/entity/Q37292441

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

New developments in the induction and antiviral effectors of type I interferon

@en

New developments in the induction and antiviral effectors of type I interferon.

@nl

type

label

New developments in the induction and antiviral effectors of type I interferon

@en

New developments in the induction and antiviral effectors of type I interferon.

@nl

prefLabel

New developments in the induction and antiviral effectors of type I interferon

@en

New developments in the induction and antiviral effectors of type I interferon.

@nl

P1433

Q37292441-407A2242-403B-40F7-8442-97276D588C83

P1476

Q37292441-38FC704B-0B88-432F-900A-7E5A7655C3CA

P2093

Q37292441-9D0C2235-E11C-44A3-8A17-6C1B015D2E0B

Q37292441-9FA5141E-5836-4C26-AE62-99C7AF640635

P2860

Q37292441-0A0A2C35-5B0E-4991-8165-9E3ED014046C

Q37292441-0B9308EE-8DD2-439B-9F2E-FFF47873377F

Q37292441-0BC8C922-E8DE-427E-AD73-0827BB8DC2B6

Q37292441-0DA4CC5D-F9DC-45B0-B247-D70598BFC027

Q37292441-0EE60934-BDE7-4C56-B497-646EA629AF64

Q37292441-18BB9CB8-BD1E-4768-9286-E4F0DABA4EF9

Q37292441-195DFC76-FF42-4C8C-91F7-F0F04DB41A65

Q37292441-1D5915DD-1D79-4BA5-B918-0D6A25C2F16F

Q37292441-20F67118-3535-40FF-A403-1795DD9ACBBB

Q37292441-25669E31-C99F-4CFF-94B8-9ADAF80FA821

P304

Q37292441-FA993248-AC88-48AC-90B7-638F9A82DA89

P31

Q37292441-05fbcbe3-c8c2-4ad1-9de6-fea6c338400b

Q37292441-0BFEEEB3-94A5-45ED-ACD2-ECA00B0D5287

P356

Q37292441-A680B200-A48D-4607-9252-9844D79439FB

P433

Q37292441-A4C289E7-08E8-4EB9-9817-8AD06C8B2F11

P478

Q37292441-DF5E8EDA-5353-4EC2-9D2A-390CFB29CC58

P50

Q37292441-A3CB1BFD-E544-4650-A2D2-41A0F80CF622

P577

Q37292441-20CF02BD-1239-4FA6-8CD9-8809A181409A

P698

Q37292441-D87F5572-0B28-4B61-87C4-64B79B7DD092

P932

Q37292441-A2EF1BC6-3909-4949-B107-F1DDAF45121F

P356

J.COI.2010.11.003

P1433

Current Opinion in Immunology

P1476

New developments in the induction and antiviral effectors of type I interferon

@en

P2093

David Jesse Sanchez

http://www.w3.org/2001/XMLSchema#string

Su-Yang Liu

http://www.w3.org/2001/XMLSchema#string

P2860

APOBEC3G encapsidation into HIV-1 virions: which RNA is it?

Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus

ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses

TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5

Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification

Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells

Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector

RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway

DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response

ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity

P304

57-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.COI.2010.11.003

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21123041

http://www.w3.org/2001/XMLSchema#string

P932

3822007

http://www.w3.org/2001/XMLSchema#string